Patent details
EP1572233 Title: Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
Basic Information
- Publication number:
- EP1572233
- PCT Application Number:
- PCT/EP/2003/014562
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP037893468
- PCT Publication Number:
- WO/2004/056389
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
- French Title of Invention:
- Utilisation de HPV16 et de HPV18 comme vaccin contre un ou plusieurs type de HPV oncogène 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
- German Title of Invention:
- Verwendung von HPV16 und HPV18 VLPs als Vakzine gegen eine oder mehrere onkogene HPV des Typus 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
- SPC Number:
Dates
- Filing date:
- 18/12/2003
- Grant date:
- 30/03/2011
- EP Publication Date:
- 30/03/2011
- PCT Publication Date:
- 08/07/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/09/2005
- EP B1 Publication Date:
- 30/03/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 18/12/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/12/2003
- Name:
- GlaxoSmithKline Biologicals s.a.
- Address:
- rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
Agent
- Name:
- KIRKPATRICK
- From:
- 19/05/2011
- Address:
- AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
- To:
Inventor
1
- Name:
- DUBIN Gary GlaxoSmithKline
- Address:
- United States (US)
2
- Name:
- INNIS Bruce GlaxoSmithKline
- Address:
- United States (US)
3
- Name:
- WETTENDORFF M.A.C. GlaxoSmithKlineBiologicals SA
- Address:
- Belgium (BE)
4
- Name:
- SLAOUI Moncef, M. GlaxoSmithKline
- Address:
- United States (US)
Priority
1
- Priority Number:
- 435035 P
- Priority Date:
- 20/12/2002
- Priority Country:
- United States (US)
2
- Priority Number:
- 496653 P
- Priority Date:
- 20/08/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 39/12;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 22/11/2022
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|